In 2023, out-of-pocket health expenditure in China stood at 32.45% of total current health expenditure. From the forecasted data, this percentage is expected to decline consistently over the next five years. Specifically, the values are projected to drop to 31.54% in 2024, 30.64% in 2025, 29.75% in 2026, 28.87% in 2027, and 28.02% in 2028. This indicates a steady annual decrease.
Year-on-year variations show a decreasing trend:
- 2024: -2.80%
- 2025: -2.85%
- 2026: -2.90%
- 2027: -2.96%
- 2028: -2.94%
The Compound Annual Growth Rate (CAGR) for the forecasted period of 2024-2028 is approximately -2.89%, indicating a consistent year-over-year reduction in out-of-pocket health expenditure as a percentage of total current health expenditure.
Future trends to watch for include the impact of government policies aimed at reducing the financial burden of healthcare on individuals and the potential effects of healthcare technologies and innovations, which could further influence out-of-pocket spending in China.
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...